Anyone verse in the technicals behind "gap filling"? Obviously with MEIP there's a huge gap created when the stock plummeted a few months ago, but has been more or less "basing" in the current price range ever since. What needs to happen technically for MEIP to start "filling in this huge price gap"? Thanks in advance for any meaningful replies!
I received the following email after my inquiry about the company's presentation this weekend -
Thanks for reaching out, Eric. We will be presenting data from all 50 patients in our Phase II study of Pracinostat in elderly AML at the European Hematology Association (EHA) meeting in Vienna this Saturday.
Please let me know if there is anything else I can do to help.
Pete De Spain
Vice President, Investor Relations &
How important are results from a Phase II study in relation to movement in stock price?